ENDLOS-TURBO PUT - AMGEN | Real-time Boerse Frankfurt Warrants 01:34:39 10/06/2024 pm IST | ||
| 13.68 EUR | +0.51% |
|
| Current month | -0.51% | ||
| 1 month | -4.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 10/24/10 | 13.68 | +0.51% |
| 07/24/07 | 13.61 | +1.87% |
| 06/24/06 | 13.36 | +0.45% |
| 05/24/05 | 13.3 | +0.38% |
| 04/24/04 | 13.25 | -0.15% |
Real-time Boerse Frankfurt Warrants
Last update June 10, 2024 at 01:34 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ85UD |
| ISIN | DE000DJ85UD3 |
| Date issued | 05/02/2024 |
| Strike | 451.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 11.93 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.08 € |
|---|---|
| Lowest since issue | 11.81 € |
| Spread | 0.27 € |
| Spread % | 1.93% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Certificates
- Certificat
